Clinical Trials
3 trialsNCT06997068 2026-05-11
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mayo Clinic
Phase 2 Recruiting
NCT07556367 2026-04-29
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
University of California, San Francisco
Phase NA Recruiting
NCT02577237 2019-02-11
Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer
Case Comprehensive Cancer Center
Phase NA Completed